tm logo
T T-DETECT
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 28 Oct 2024

Last Applicant/ Owned by

1551 Eastlake Ave. E, Suite 200

Seattle

WA

98102

Serial Number

97444992 filed on 06th Jun 2022

Registration Number

N/A

Correspondent Address

Hoang-chi Truong

Hoang-chi Truong Patent Law Works LLP

SALT LAKE CITY, UT 84107

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

T T-DETECT

Providing information about medical research in the field medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scienti Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical diagnostic and prognostic testing services; providing medical immunosequencing-based diagnostic and prognostic testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services relating to the diagnosis and treatment of persons


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Providing information about medical research in the field medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; medical laboratory immunosequencing-based services for analysis of biological samples


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use, namely, to detect cancer, autoimmune disease and infection; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use , namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97444992

Mark Type

No Service Mark

Attorney Docket Number

No 10214-2-048

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.09 -

Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle

26.03.14 -

Three or more ovals

26.03.21 -

Ovals that are completely or partially shaded

26.03.28 -

Miscellaneous designs with overall oval shape, including amoeba-like shapes and irregular ovals

Legal History


Show more

Status DateAction Taken
28th Oct 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
28th Oct 2024ABANDONMENT - NO USE STATEMENT FILED
23rd Mar 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Mar 2024SOU EXTENSION 1 GRANTED
22nd Mar 2024SOU TEAS EXTENSION RECEIVED
22nd Mar 2024SOU EXTENSION 1 FILED
26th Sep 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01st Aug 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01st Aug 2023PUBLISHED FOR OPPOSITION
12th Jul 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED